- Home
- NAUT vs SGMO Comparison
NAUT vs SGMO Comparison
Compare NAUT & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAUT
- SGMO
- Stock Information
- Founded
- NAUT 2016
- SGMO 1995
- Country
- NAUT United States
- SGMO United States
- Employees
- NAUT N/A
- SGMO N/A
- Industry
- NAUT Biotechnology: Laboratory Analytical Instruments
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NAUT Industrials
- SGMO Health Care
- Exchange
- NAUT Nasdaq
- SGMO Nasdaq
- Market Cap
- NAUT 104.7M
- SGMO 122.8M
- IPO Year
- NAUT N/A
- SGMO 2000
- Fundamental
- Price
- NAUT $1.82
- SGMO $0.45
- Analyst Decision
- NAUT Strong Sell
- SGMO Buy
- Analyst Count
- NAUT 1
- SGMO 7
- Target Price
- NAUT $1.75
- SGMO $4.71
- AVG Volume (30 Days)
- NAUT 790.4K
- SGMO 4.6M
- Earning Date
- NAUT 10-28-2025
- SGMO 11-06-2025
- Dividend Yield
- NAUT N/A
- SGMO N/A
- EPS Growth
- NAUT N/A
- SGMO N/A
- EPS
- NAUT N/A
- SGMO N/A
- Revenue
- NAUT N/A
- SGMO $32,875,000.00
- Revenue This Year
- NAUT N/A
- SGMO $28.47
- Revenue Next Year
- NAUT N/A
- SGMO N/A
- P/E Ratio
- NAUT N/A
- SGMO N/A
- Revenue Growth
- NAUT N/A
- SGMO N/A
- 52 Week Low
- NAUT $0.62
- SGMO $0.41
- 52 Week High
- NAUT $2.51
- SGMO $2.84
- Technical
- Relative Strength Index (RSI)
- NAUT 64.84
- SGMO 29.91
- Support Level
- NAUT $1.60
- SGMO $0.42
- Resistance Level
- NAUT $1.91
- SGMO $0.53
- Average True Range (ATR)
- NAUT 0.21
- SGMO 0.04
- MACD
- NAUT 0.02
- SGMO -0.01
- Stochastic Oscillator
- NAUT 84.13
- SGMO 11.96
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.